Products for Research Use Only
RegisterLogin

Kylo-0603

CAT: 0804-HY-172661Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-172661Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KYLO-0603 is an orally active, selective THR-β agonist (EC50: 31.07 nM) . KYLO-0603 has significant activity in lowering serum cholesterol and low-density lipoprotein cholesterol. KYLO-0603 upregulates the expression of THR-regulated genes (including iodothyronine deiodinase 1 (Dio1), malic enzyme 1 (Me1), and thyroid hormone response (Thrsp) gene) and inhibits the expression of inflammatory and fibrotic genes (low-density lipoprotein receptor (LDL-R) gene) by activating THR-β receptors. KYLO-0603 can be used to treat metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis research[1].
CAS Number
2661053-09-2
UNSPSC
12352005
Target
Interleukin Related; LDLR; Thyroid Hormone Receptor
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Field of Research
Infection; Metabolic Disease
Smiles
O=C(CCOCC(COCCC(NCCCCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)=O)(NC(CCCCCNC(COC2=CC(C)=C(CC3=CC(C(C)C)=C(O)C=C3)C(C)=C2)=O)=O)COCCC(NCCCCCCO[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)=O)NCCCCCCO[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5NC(C)=O
Molecular Formula
C81H134N8O28
Molecular Weight
1667.97
References & Citations
[1]Xueqin lu, et al. KYLO-0603, a novel liver-targeting, thyroid hormone receptor-β agonist for the treatment of MASH. bioRxiv 2025.02.09.637336
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-10244-01MK-0608
HY-U00354CP-060
HY-149085-01XS-060
HY-144266-01TP-060
HY-149085A(E) -XS-060
HY-P2264-01KYL peptide

Alternative Products

CatalogName
GTR19258087-01Kylo-0603
GX7358-50gSilver on Activated Carbon 0,5% Ag/C (Heraeus-Type K-0603)

Popular Products